Colgate-Palmolive Company (CL)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 09-2005 | 06-2005 | 03-2005 | 12-2004 | 09-2004 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 376,300 | 392,100 | 413,900 | 319,600 | 370,600 |
| Receivables | 1,337,200 | 1,315,400 | 1,316,200 | 1,319,900 | 1,286,700 |
| Inventories | 890,400 | 915,700 | 906,700 | 845,500 | 863,400 |
| Other current assets | 293,600 | 306,200 | 307,400 | 254,900 | 295,200 |
| TOTAL | $2,897,500 | $2,929,400 | $2,944,200 | $2,739,900 | $2,815,900 |
| Non-Current Assets | |||||
| PPE Net | 2,558,500 | 2,548,600 | 2,553,800 | 2,647,700 | 2,529,500 |
| Intangibles | 2,665,000 | 2,639,200 | 2,674,600 | 2,724,100 | 2,579,800 |
| Other Non-Current Assets | 533,900 | 550,000 | 518,900 | 561,200 | 564,400 |
| TOTAL | $5,757,400 | $5,737,800 | $5,747,300 | $5,933,000 | $5,673,700 |
| Total Assets | $8,654,900 | $8,667,200 | $8,691,500 | $8,672,900 | $8,489,600 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 346,500 | 313,000 | 672,500 | 451,300 | 414,700 |
| Accounts payable and accrued liabilities | 804,800 | 815,500 | 816,700 | 864,400 | 784,600 |
| TOTAL | $2,758,400 | $2,465,200 | $3,090,800 | $2,730,700 | $2,631,500 |
| Non-Current Liabilities | |||||
| Long Term Debt | 3,017,200 | 3,455,100 | 2,969,900 | 3,089,500 | 3,120,700 |
| Other Non-Current Liabilities | 1,045,700 | 1,056,000 | 1,105,700 | 1,097,700 | 1,035,900 |
| TOTAL | $4,593,800 | $5,007,100 | $4,585,700 | $4,696,800 | $4,611,000 |
| Total Liabilities | $7,352,200 | $7,472,300 | $7,676,500 | $7,427,500 | $7,242,500 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 1,036,110 | 1,038,852 | 1,046,357 | 1,050,430 | 1,060,570 |
| Common Shares | 732,900 | 732,900 | 732,900 | 732,900 | 732,900 |
| Retained earnings | 8,771,000 | 8,575,700 | 8,244,200 | 8,223,900 | 8,077,000 |
| Other shareholders' equity | -2,047,000 | -2,077,100 | -2,128,000 | -2,114,200 | -2,149,000 |
| TOTAL | $1,302,700 | $1,194,900 | $1,015,000 | $1,245,400 | $1,247,100 |
| Total Liabilities And Equity | $8,654,900 | $8,667,200 | $8,691,500 | $8,672,900 | $8,489,600 |